Tokyo Tape
Sign in
← Medical Ikkou Group

Quarterly report · Q2

3353.TEDINET S100PCTW
Period2022-03-01 → 2022-08-31
Filed2022-10-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥17.0bn2022-03-01 → 2022-08-31Cons.Net sales
Revenue¥33.6bn2021-03-01 → 2022-02-28Cons.Net sales (5-year summary)
Revenue¥16.8bn2021-03-01 → 2021-08-31Cons.Net sales
Operating income¥466m2022-03-01 → 2022-08-31Cons.Operating income
Operating income¥645m2021-03-01 → 2021-08-31Cons.Operating income
Ordinary income¥598m2022-03-01 → 2022-08-31Cons.Ordinary income
Ordinary income¥1.4bn2021-03-01 → 2022-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥682m2021-03-01 → 2021-08-31Cons.Ordinary income
Profit before tax¥624m2022-03-01 → 2022-08-31Cons.Income before income taxes
Profit before tax¥781m2021-03-01 → 2021-08-31Cons.Income before income taxes
Net income (owners)¥374m2022-03-01 → 2022-08-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥852m2021-03-01 → 2022-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥444m2021-03-01 → 2021-08-31Cons.Profit loss attributable to owners of parent
Net income¥386m2022-03-01 → 2022-08-31Cons.Profit loss
Net income¥452m2021-03-01 → 2021-08-31Cons.Profit loss
Total assets¥28.3bnat 2022-08-31Cons.Assets
Total assets¥29.1bnat 2022-02-28Cons.Assets
Total assets¥30.2bnat 2021-08-31Cons.Total assets (5-year summary)
Total liabilities¥16.1bnat 2022-08-31Cons.Liabilities
Total liabilities¥17.2bnat 2022-02-28Cons.Liabilities
Net assets / equity¥12.2bnat 2022-08-31Cons.Net assets
Net assets / equity¥11.9bnat 2022-02-28Cons.Net assets
Net assets / equity¥11.6bnat 2021-08-31Cons.Net assets (5-year summary)
Cash and deposits¥7.0bnat 2022-08-31Cons.Cash and deposits
Cash and deposits¥8.0bnat 2022-02-28Cons.Cash and deposits
Cash & equivalents¥6.8bnat 2022-08-31Cons.Cash and cash equivalents
Cash & equivalents¥7.8bnat 2022-02-28Cons.Cash and cash equivalents
Cash & equivalents¥8.4bnat 2021-08-31Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2021-02-28dCons.Cash and cash equivalents
Operating cash flow¥496m2022-03-01 → 2022-08-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-03-01 → 2022-02-28Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥334m2021-03-01 → 2021-08-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥291m2022-03-01 → 2022-08-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥216m2021-03-01 → 2022-02-28Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥47m2021-03-01 → 2021-08-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.2bn2022-03-01 → 2022-08-31Cons.Net cash provided by used in financing activities
Financing cash flow¥65m2021-03-01 → 2022-02-28Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.3bn2021-03-01 → 2021-08-31Cons.Net cash provided by used in financing activities
EPS (basic)¥99.652022-03-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥44.262022-06-01 → 2022-08-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥226.922021-03-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥118.222021-03-01 → 2021-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.132021-06-01 → 2021-08-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio41.2%at 2022-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio36.6%at 2021-08-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-08-31−¥497m
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-08-31−¥497m
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-08-31−¥385m
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2022-08-31¥11.6bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2022-08-31¥11.6bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2022-08-31¥736m
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue2022-03-01 → 2022-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue external2022-03-01 → 2022-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥300,000
jpcrp040300-q2r_E03443-000Health Carereportable segmentsegment profit2022-03-01 → 2022-08-31¥35m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2022-08-31¥1.9bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2022-08-31¥1.4bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥495m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2022-08-31¥20m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue2022-03-01 → 2022-08-31¥95m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue external2022-03-01 → 2022-08-31¥94m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥876,000
jpcrp040300-q2r_E03443-000Real Estatereportable segmentsegment profit2022-03-01 → 2022-08-31¥61m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-08-31¥17.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-08-31¥17.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-08-31¥497m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-08-31¥851m
Reconciling Itemsreconcilingrevenue2021-03-01 → 2021-08-31−¥545m
Reconciling Itemsreconcilingrevenue intersegment2021-03-01 → 2021-08-31−¥545m
Reconciling Itemsreconcilingsegment profit2021-03-01 → 2021-08-31−¥347m
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue2021-03-01 → 2021-08-31¥11.3bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2021-03-01 → 2021-08-31¥11.3bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2021-03-01 → 2021-08-31¥731m
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue2021-03-01 → 2021-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue external2021-03-01 → 2021-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue intersegment2021-03-01 → 2021-08-31¥300,000
jpcrp040300-q2r_E03443-000Health Carereportable segmentsegment profit2021-03-01 → 2021-08-31¥146m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue2021-03-01 → 2021-08-31¥2.0bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue external2021-03-01 → 2021-08-31¥1.4bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2021-03-01 → 2021-08-31¥543m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentsegment profit2021-03-01 → 2021-08-31¥50m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue2021-03-01 → 2021-08-31¥117m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue external2021-03-01 → 2021-08-31¥116m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue intersegment2021-03-01 → 2021-08-31¥960,000
jpcrp040300-q2r_E03443-000Real Estatereportable segmentsegment profit2021-03-01 → 2021-08-31¥65m
Total Of Reportable Segments And Otherssegment totalrevenue2021-03-01 → 2021-08-31¥17.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-03-01 → 2021-08-31¥16.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-03-01 → 2021-08-31¥545m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-03-01 → 2021-08-31¥992m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 501
ItemContextValueUnit
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-544726000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E03443-000DispensingPharmacyReportableSegmentsMember11336945000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E03443-000HealthCareReportableSegmentsMember3935898000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E03443-000MedicalProductsWholesaleReportableSegmentsMember1967741000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E03443-000RealEstateReportableSegmentsMember117135000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember17357721000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-544726000JPY
Net salesPrior1YTDDuration16812994000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E03443-000DispensingPharmacyReportableSegmentsMember730689000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E03443-000HealthCareReportableSegmentsMember145734000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E03443-000MedicalProductsWholesaleReportableSegmentsMember50380000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E03443-000RealEstateReportableSegmentsMember65317000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember992122000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-347018000JPY
Operating incomePrior1YTDDuration645104000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E03443-000DispensingPharmacyReportableSegmentsMember11580107000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E03443-000HealthCareReportableSegmentsMember3901925000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E03443-000MedicalProductsWholesaleReportableSegmentsMember1402634000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E03443-000RealEstateReportableSegmentsMember94322000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember16978990000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration16978990000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E03443-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E03443-000HealthCareReportableSegmentsMember300000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E03443-000MedicalProductsWholesaleReportableSegmentsMember495372000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E03443-000RealEstateReportableSegmentsMember876000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember496549000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-496549000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E03443-000DispensingPharmacyReportableSegmentsMember11580107000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E03443-000HealthCareReportableSegmentsMember3902225000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E03443-000MedicalProductsWholesaleReportableSegmentsMember1898007000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E03443-000RealEstateReportableSegmentsMember95199000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember17475539000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-496549000JPY
Net salesCurrentYTDDuration16978990000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E03443-000DispensingPharmacyReportableSegmentsMember736051000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E03443-000HealthCareReportableSegmentsMember34684000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E03443-000MedicalProductsWholesaleReportableSegmentsMember19623000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E03443-000RealEstateReportableSegmentsMember60541000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember850901000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-385256000JPY
Operating incomeCurrentYTDDuration465645000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)東海財務局長
Filing date cover pageFilingDateInstant2022-10-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第38期第２四半期（自 2022年６月１日　至 2022年８月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社メディカル一光グループ

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-02-28pass
balance sheet identityconsolidated 2022-08-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2022-08-31pass
statement vs summary · net income attributable to parentconsolidated 2021-03-01/2021-08-31pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-08-31pass
statement vs summary · operating cash flowconsolidated 2021-03-01/2021-08-31pass
statement vs summary · operating cash flowconsolidated 2022-03-01/2022-08-31pass
statement vs summary · revenueconsolidated 2021-03-01/2021-08-31pass
statement vs summary · revenueconsolidated 2022-03-01/2022-08-31pass
statement vs summary · total assetsconsolidated 2022-02-28pass
statement vs summary · total assetsconsolidated 2022-08-31pass